On this page
Refacto
Antihemophilic Factor (Recombinant)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Refacto
Proper name
Antihemophilic Factor (Recombinant)
Licence type
351(a)
BLA number
103779
Applicant
Wyeth Pharmaceuticals LLC
Center
CBER
Presentations
4
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1000IU | For Injection | Intravenous | Vial | Disc | July 6, 2001 |
| 2000IU | For Injection | Intravenous | Vial | Disc | June 27, 2001 |
| 250IU | For Injection | Intravenous | Vial | Disc | July 6, 2001 |
| 500IU | For Injection | Intravenous | Vial | Disc | July 6, 2001 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |